Factor Xa inhibitors (DOACs): Pharmacology Made Easy & Relevant episode artwork

EPISODE · Jan 14, 2026 · 36 MIN

Factor Xa inhibitors (DOACs): Pharmacology Made Easy & Relevant

from This Is Why with Dr. Busti · host Anthony Busti, MD, PharmD, MSc, FNLA, FAHA

Factor Xa inhibitors (DOACs) made easy—fast, clear, and clinically relevant. In this lecture from This is Why, Dr. Busti will break down direct oral anticoagulants (DOACs) and how Factor Xa inhibitors work, with relevance.You’ll learn how to:- What Factor Xa inhibitors do (mechanism of action)- Key drugs: Apixaban (Eliquis), Rivaroxaban (Xarelto), Edoxaban (Savaysa)- Common indications: Afib stroke prevention, DVT/PE treatment- Major adverse effects and safety: bleeding risk, interactions, and monitoring pearls- Reversal overview: What to know + when it mattersThe goal = make medical education easy and clinically relevant.👉 Access bonus materials and downloads from this episode at: https://www.thisiswhy.health/topics/doac-factor-xa-inhibitors-anticoagulants-pharmacology-review👉 Get more with a free membership at https://www.thisiswhy.health/- Access free downloads from our videos - Access deep dive content from Dr. Busti- Organize content via playlists & collections- Join live Q&A- Receive member newsletters- Coupons & discounts for exam prep resources👍 If this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.🔔 Don’t forget to turn on notifications so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!#FactorXaInhibitors #DOACs #Anticoagulation #Apixaban #drbustiDisclaimer:This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.

Episode metadata supplied by the publisher feed · Published Jan 14, 2026

Embed this episode

Factor Xa inhibitors (DOACs) made easy—fast, clear, and clinically relevant. In this lecture from This is Why, Dr. Busti will break down direct oral anticoagulants (DOACs) and how Factor Xa inhibitors work, with relevance. You’ll learn how to: - What Factor Xa inhibitors do (mechanism of action) - Key drugs: Apixaban (Eliquis), Rivaroxaban (Xarelto), Edoxaban (Savaysa) - Common indications: Afib stroke prevention, DVT/PE treatment - Major adverse effects and safety: bleeding risk, interactio...

Distinct summary based on available episode metadata or transcript content.

NOW PLAYING

Factor Xa inhibitors (DOACs): Pharmacology Made Easy & Relevant

0:00 36:58

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of This Is Why with Dr. Busti?

This episode is 36 minutes long.

When was this This Is Why with Dr. Busti episode published?

This episode was published on January 14, 2026.

Can I download this This Is Why with Dr. Busti episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!